NAPOLEON PERDIS FOUNDATION BROAD SPECTRUM SPF 15 LOOK 3

Manufacturer: Napoleon Perdis Cosmetics, Inc
Effective date: 2021-12-23
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-01 22:21:20

Label at a glance#

ProductNAPOLEON PERDIS FOUNDATION BROAD SPECTRUM SPF 15 LOOK 3

Active ingredientOCTINOXATE, OCTISALATE, TITANIUM DIOXIDE

Label structure9 sections

Indications and uses

Helps to prevent sunburn.

Dosage and administration

Apply evenly before sun exposure. Children under 6 months of age: ask a doctor. Reapply as needed or after towel drying, swimming or sweating.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

OCTINOXATE 7.5%
OCTISALATE 5.0%
TITANIUM DIOXIDE 2.0%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INDICATIONS & USAGE SECTION

Helps to prevent sunburn.

Warnings

WARNINGS SECTION

For external use only.

When using this product:

OTC - WHEN USING SECTION

keep out of eyes. Rinse with water to remove.

Stop use and see a doctor if

OTC - STOP USE SECTION

rash or irritation develops and lasts.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply evenly before sun exposure. Children under 6 months of age: ask a doctor. Reapply as needed or after towel drying, swimming or sweating.

Other information

SPL UNCLASSIFIED SECTION

Moderate sun protection product. Sun alert: limiting sun exposure, wearing protective clothing and using sunscreens may reduce the risks of sun aging, skin cancer, and other harmful effects of the sun. Protect this product from excessive heat and direct sun.

Inactive ingredients:

INACTIVE INGREDIENT SECTION

ETHYLHEXYL PALMITATE, CAPRYLIC/CAPRIC TRIGLYCERIDE, CETYL DIMETHICONE, SILICA, BEESWAX (CERA ALBA), EUPHORBIA CERIFERA (CANDELILLA) WAX (CANDELILLA CERA), OZOKERITE, NYLON-12, PROPYLENE GLYCOL LAURATE, OCTYLDODECYL NEOPENTANOATE, OCTYLDODECANOL, ALOE BARBADENSIS LEAF EXTRACT, GLYCINE SOJA (SOYBEAN) OIL, TOCOPHEROL, ASCORBYL PALMITATE, TRIETHOXYCAPRYLYLSILANE, CETYL PALMITATE, CAPRYLYL GLYCOL, MAY CONTAIN: MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491, CI 77492, CI 77499).

"Build the best foundation - and stick to it!" - NAPOLEON

SPL UNCLASSIFIED SECTION

Meet the ultimate camouflage agent. This double-duty, long-lasting foundation provides buildable coverage to suit your needs - from minimal to maximum coverage with a modern matte finish. It also offers broad-spectrum SPF 15 and doubles as a great concealer.

PRO TIP

For lighter coverage, mix with Auto Pilot Pre-Foundation Skin Primer and concentrate on the feature focus area of the face.

Conceived by Napoleon Perdis, Hollywood, USA Distributed by Napoleon Perdis, Los Angeles, USA Made in USA 12M napoleonperdis.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

napoleon PERDIS FOUNDATION STICK BROAD SPECTRUM SPF 15 Net Wt. 14 g / 0.5 oz

Product Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Look 3 Shade LabelFoundation Stick

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51386-733-00	2021-01-07	C162847	48780-1	9d75b9d1-0d26-f424-e053-dadaa90a57ce	napoleon PERDIS FOUNDATION STICK BROAD SPECTRUM SPF 15 Look 3
51386-733-00	2020-01-31	C162847	48780-1	9d75b9d1-0d26-f424-e053-dadaa90a57ce	napoleon PERDIS FOUNDATION STICK BROAD SPECTRUM SPF 15 Look 3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	1
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	1
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	1
ASCORBYL PALMITATE	INACTIVE INGREDIENT	QN83US2B0N	1
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	1
CETYL PALMITATE	INACTIVE INGREDIENT	5ZA2S6B08X	1
ETHYLHEXYL PALMITATE	INACTIVE INGREDIENT	2865993309	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	1
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	1
NYLON-12	INACTIVE INGREDIENT	446U8J075B	1
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	1
OCTYLDODECYL NEOPENTANOATE	INACTIVE INGREDIENT	X8725R883T	1
PROPYLENE GLYCOL MONOLAURATE	INACTIVE INGREDIENT	668Z5835Z3	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SOYBEAN OIL	INACTIVE INGREDIENT	241ATL177A	1
TOCOPHEROL	INACTIVE INGREDIENT	R0ZB2556P8	1
TRIETHOXYCAPRYLYLSILANE	INACTIVE INGREDIENT	LDC331P08E	1
YELLOW WAX	INACTIVE INGREDIENT	2ZA36H0S2V	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NAPOLEON PERDIS FOUNDATION BROAD SPECTRUM SPF 15 LOOK 3
OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE
ETHYLHEXYL PALMITATE
MEDIUM-CHAIN TRIGLYCERIDES
SILICON DIOXIDE
YELLOW WAX
CANDELILLA WAX
NYLON-12
PROPYLENE GLYCOL MONOLAURATE
OCTYLDODECYL NEOPENTANOATE
OCTYLDODECANOL
ALOE VERA LEAF
SOYBEAN OIL
TOCOPHEROL
ASCORBYL PALMITATE
TRIETHOXYCAPRYLYLSILANE
CETYL PALMITATE
CAPRYLYL GLYCOL
MICA
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE
OCTINOXATE
OCTISALATE
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51386-733	51386-733-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ETHYLHEXYL PALMITATE	2865993309	IACT
MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
YELLOW WAX	2ZA36H0S2V	IACT
CANDELILLA WAX	WL0328HX19	IACT
NYLON-12	446U8J075B	IACT
PROPYLENE GLYCOL MONOLAURATE	668Z5835Z3	IACT
OCTYLDODECYL NEOPENTANOATE	X8725R883T	IACT
OCTYLDODECANOL	461N1O614Y	IACT
ALOE VERA LEAF	ZY81Z83H0X	IACT
SOYBEAN OIL	241ATL177A	IACT
TOCOPHEROL	R0ZB2556P8	IACT
ASCORBYL PALMITATE	QN83US2B0N	IACT
TRIETHOXYCAPRYLYLSILANE	LDC331P08E	IACT
CETYL PALMITATE	5ZA2S6B08X	IACT
CAPRYLYL GLYCOL	00YIU5438U	IACT
MICA	V8A1AW0880	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
OCTINOXATE	4Y5P7MUD51	ACTIB
OCTISALATE	4X49Y0596W	ACTIB
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 167 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	FILM / BUCCAL	0.27 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	INJECTION, EMULSION / INTRAVENOUS	1.1 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TAMPON / VAGINAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	POWDER, FOR SUSPENSION / ORAL	3390 mg/5ml		Exact identifier — unii candidate 18 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	SUSPENSION / TOPICAL	2.01 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	INJECTION, EMULSION / INTRAVENOUS	0.02 %w/v		Exact identifier — unii candidate 5 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	GEL / TOPICAL		12 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	FILM / TRANSDERMAL	32.44 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SOLUTION / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, DELAYED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL		2 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
YELLOW WAX	YELLOW WAX	2ZA36H0S2V	CREAM / TOPICAL	5 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SOYBEAN OIL	SOYBEAN OIL	241ATL177A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	10 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, COATED / ORAL		1 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	AEROSOL, FOAM / TOPICAL	10.87 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	CREAM / VAGINAL	13.5 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FOR SUSPENSION / ORAL		220 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, EXTENDED RELEASE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	LOTION / TOPICAL		714 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	SUSPENSION, EXTENDED RELEASE / ORAL	2.7 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
PROPYLENE GLYCOL MONOLAURATE	PROPYLENE GLYCOL MONOLAURATE	668Z5835Z3	GEL / TOPICAL	3 %w/w		Exact identifier — unii candidate 5 equally ranked IID candidates
YELLOW WAX	YELLOW WAX	2ZA36H0S2V	TABLET, DELAYED RELEASE / ORAL	0.1 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	CAPSULE, DELAYED RELEASE / ORAL		3 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
CANDELILLA WAX	CANDELILLA WAX	WL0328HX19	TABLET, DELAYED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE, DELAYED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE, COATED / ORAL	0.11 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SOYBEAN OIL	SOYBEAN OIL	241ATL177A	INJECTION / INTRAVENOUS	10 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	PASTE / DENTAL	34 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	CAPSULE, COATED / ORAL	0.01 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / NASAL		20 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SOLUTION / ORAL	1.8 mg/120ml		Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		69 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CETYL PALMITATE	CETYL PALMITATE	5ZA2S6B08X	SOLUTION / TOPICAL	0.05 %w/w		Exact identifier — unii candidate 4 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDES	MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	SOLUTION / ORAL		5566 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	SYSTEM / TRANSDERMAL	4.05 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
CETYL PALMITATE	CETYL PALMITATE	5ZA2S6B08X	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 4 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	GRANULE, FOR SUSPENSION / ORAL		11 mg	Exact identifier — unii candidate 20 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
d3dd74dd-0718-2aa5-e053-2a95a90a8211			d1315551-92b3-4aca-8294-e70783cf85f5	2021-12-23	Warnings	Exact identifier spl id: d3dd74dd-0718-2aa5-e053-2a95a90a8211 spl set id: d1315551-92b3-4aca-8294-e70783cf85f5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.